$ITP
IT TECH PACKAGING, INC. Stock $itp

$itp Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023038552 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$30.02M	$19.79M	$15.48M
YoY Change	-5.56%	27.83%	-36.05%
Cost Of Revenue	$28.84M	$20.07M	$15.17M
YoY Change	-7.43%	32.28%	-32.21%
Gross Profit	$1.180M	-$277.0K	$310.5K
YoY Change	86.09%	-189.22%	-83.04%
Gross Profit Margin	3.93%	-1.4%	2.01%
Selling, General & Admin	$1.323M	$2.495M	$3.301M
YoY Change	-29.22%	-24.4%	29.18%
% of Gross Profit	112.17%		1063.26%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.464M	$3.686M	$3.773M
YoY Change	-9.3%	-2.31%	-7.8%
% of Gross Profit	293.58%		1215.41%
Operating Expenses	$1.323M	$2.495M	$3.301M
YoY Change	-29.22%	-24.4%	29.18%
Operating Profit	-$518.7K	-$2.772M	-$2.990M
YoY Change	-58.03%	-7.29%	312.87%
Interest Expense	$270.7K	$249.2K	$119.2K
YoY Change	-61.65%	108.98%	-103.05%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$902.2K	-$2.733M	-$2.837M
YoY Change	69.68%	-3.67%	-36.09%
Income Tax	$351.3K		-$349.0K
% Of Pretax Income
Net Earnings	-$1.253M	-$2.733M	-$2.488M
YoY Change	335.38%	9.84%	-42.65%
Net Earnings / Revenue	-4.18%	-13.81%	-16.07%
Basic Earnings Per Share	-$0.12	-$0.27	-$0.25
Diluted Earnings Per Share	-$0.12	-$0.27	-$251.2K
COMMON SHARES
Basic Shares Outstanding	10.07M shares	10.07M shares	9.916M shares
Diluted Shares Outstanding	10.07M shares	10.07M shares	9.916M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.98M	$16.75M	$15.36M
YoY Change	-16.48%	9.07%	-58.98%
Cash & Equivalents	$11.98M	$16.75M	$15.36M
Short-Term Investments
Other Short-Term Assets	$19.26M	$18.73M	$8.290M
YoY Change	116.52%	125.99%	80.68%
Inventory	$6.569M	$5.970M	$4.355M
Prepaid Expenses	$763.00	$27.83K
Receivables	$2.417M	$2.232M	$4.985M
Other Receivables	$7.459M	$7.795M	$15.63M
Total Short-Term Assets	$47.69M	$51.48M	$48.62M
YoY Change	-1.56%	5.9%	-20.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$142.0M	$149.8M	$176.3M
YoY Change	-13.02%	-15.03%	23.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.669M	$881.9K	$11.67M
YoY Change	-76.79%	-92.44%	-66.85%
Total Long-Term Assets	$149.1M	$155.4M	$190.4M
YoY Change	-15.8%	-18.4%	5.69%
TOTAL ASSETS
Total Short-Term Assets	$47.69M	$51.48M	$48.62M
Total Long-Term Assets	$149.1M	$155.4M	$190.4M
Total Assets	$196.7M	$206.8M	$239.0M
YoY Change	-12.74%	-13.46%	-0.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$127.5K		$72.62K
YoY Change	645.87%		-96.92%
Accrued Expenses	$586.5K	$616.7K	$2.422M
YoY Change	-75.45%	-74.54%	36.95%
Deferred Revenue
YoY Change
Short-Term Debt	$5.742M	$5.674M	$5.984M
YoY Change	-3.64%	-5.19%	-6.35%
Long-Term Debt Due	$3.762M	$5.265M	$7.096M
YoY Change	-18.84%	-25.8%	37.8%
Total Short-Term Liabilities	$17.30M	$18.13M	$19.94M
YoY Change	-0.17%	-9.07%	-1.35%
LONG-TERM LIABILITIES
Long-Term Debt	$7.437M	$7.102M	$3.077M
YoY Change	50.63%	130.78%	-36.77%
Other Long-Term Liabilities	$1.227M	$524.5K	$1.808M
YoY Change	50.04%	-70.99%	-84.84%
Total Long-Term Liabilities	$8.664M	$7.626M	$4.885M
YoY Change	50.55%	56.1%	-70.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.30M	$18.13M	$19.94M
Total Long-Term Liabilities	$8.664M	$7.626M	$4.885M
Total Liabilities	$25.97M	$25.76M	$24.82M
YoY Change	12.48%	3.76%	-32.92%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$10.07K	$10.07K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$170.8M	$181.1M	$214.2M
YoY Change
Total Liabilities & Shareholders Equity	$196.7M	$206.8M	$239.0M
YoY Change	-12.74%	-13.46%	-0.94%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.253M	-$2.733M	-$2.488M
YoY Change	335.38%	9.84%	-42.65%
Depreciation, Depletion And Amortization	$3.464M	$3.686M	$3.773M
YoY Change	-9.3%	-2.31%	-7.8%
Cash From Operating Activities	$936.8K	$4.810M	$4.411M
YoY Change	-302.93%	9.03%	-153.28%
INVESTING ACTIVITIES
Capital Expenditures	$5.271M	$295.0K	-$368.5K
YoY Change	-1783.17%	-180.06%	726.23%
Acquisitions			$6.807M
YoY Change
Other Investing Activities	$0.00	$0.00	-$6.807M
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$5.271M	-$295.0K	-$7.176M
YoY Change	3453.11%	-95.89%	15989.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	259.0K	$2.565M	6.893M
YoY Change	-218.07%	-62.8%	-83.51%
NET CHANGE
Cash From Operating Activities	936.8K	$4.810M	4.411M
Cash From Investing Activities	-5.271M	-$295.0K	-7.176M
Cash From Financing Activities	259.0K	$2.565M	6.893M
Net Change In Cash	-4.075M	$7.226M	4.129M
YoY Change	391.37%	75.02%	-87.66%
FREE CASH FLOW
Cash From Operating Activities	$936.8K	$4.810M	$4.411M
Capital Expenditures	$5.271M	$295.0K	-$368.5K
Free Cash Flow	-$4.334M	$4.515M	$4.780M
YoY Change	2818.45%	-5.54%	-158.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	itp	Subsidy Income SubsidyIncome		usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue		usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue		usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-34577
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	IT TECH PACKAGING, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-4158835
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	Science Park
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Juli Rd
CY2023Q1	dei	Entity Address Address Line3 EntityAddressAddressLine3	Xushui District
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Baoding City
CY2023Q1	dei	Entity Address Country EntityAddressCountry	CN
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	072550
CY2023Q1	dei	City Area Code CityAreaCode	(86)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	312-8698215
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
CY2023Q1	dei	Trading Symbol TradingSymbol	ITP
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10065920	shares
CY2023Q1	us-gaap	Cash Cash	16750940	usd
CY2022Q4	us-gaap	Cash Cash	9524868	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	647787	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	881878	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	2231924	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	5969604	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2872622	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18734461	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27207127	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	7795442	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	7561858	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	51482371	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	47166475	usd
CY2023Q1	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	881878	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	1031502	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	681817	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	672722	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1927390	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1939970	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	149822883	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	151569898	usd
CY2023Q1	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	2053290	usd
CY2022Q4	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	2066666	usd
CY2023Q1	us-gaap	Assets Assets	206849629	usd
CY2022Q4	us-gaap	Assets Assets	204447233	usd
CY2023Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	5673996	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	5598311	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	5265073	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4835884	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	171768	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	224497	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5025	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	730387	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	727462	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	295024	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	165986	usd
CY2023Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	5993904	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	5665558	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	417906	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	18130152	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17640629	usd
CY2023Q1	us-gaap	Deferred Revenue And Credits Current DeferredRevenueAndCreditsCurrent	6513672	usd
CY2022Q4	us-gaap	Deferred Revenue And Credits Current DeferredRevenueAndCreditsCurrent	4204118	usd
CY2023Q1	itp	Deferred Gain On Saleleaseback DeferredGainOnSaleleaseback	30298	usd
CY2022Q4	itp	Deferred Gain On Saleleaseback DeferredGainOnSaleleaseback	52314	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	587838	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	579997	usd
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	494186	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	646283	usd
CY2023Q1	itp	Variable Interest Entity Consolidated Carrying Amount Liabilities1 VariableInterestEntityConsolidatedCarryingAmountLiabilities1	19412310	usd
CY2022Q4	itp	Variable Interest Entity Consolidated Carrying Amount Liabilities1 VariableInterestEntityConsolidatedCarryingAmountLiabilities1	16784878	usd
CY2023Q1	us-gaap	Liabilities Liabilities	25756146	usd
CY2022Q4	us-gaap	Liabilities Liabilities	23123341	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10065920	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10065920	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10065920	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10065920	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	10066	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10066	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	89172771	usd
CY2022Q1	itp	Subsidy Income SubsidyIncome		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	89172771	usd
CY2023Q1	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	6080574	usd
CY2022Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	6080574	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5011784	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7514540	usd
CY2023Q1	us-gaap	Retained Earnings Unappropriated RetainedEarningsUnappropriated	90841856	usd
CY2022Q4	us-gaap	Retained Earnings Unappropriated RetainedEarningsUnappropriated	93575021	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	181093483	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	181323892	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	206849629	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	204447233	usd
CY2023Q1	us-gaap	Revenues Revenues	19790877	usd
CY2022Q1	us-gaap	Revenues Revenues	15481618	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	20067876	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	15171173	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-276999	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	310445	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2495362	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3300881	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2772361	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2990436	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	136268	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	3455	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	249169	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	270813	usd
CY2022Q1	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	34003	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	152097	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	386588	usd
CY2023Q1	itp	Income Loss Before Income Taxes IncomeLossBeforeIncomeTaxes	-2733165	usd
CY2022Q1	itp	Income Loss Before Income Taxes IncomeLossBeforeIncomeTaxes	-2837203	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-348989	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2733165	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2488214	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2502756	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	926138	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-230409	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1562076	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10065920	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9915920	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2733165	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2488214	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3686243	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3773236	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	152097	usd
CY2022Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	386588	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12926	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-246386	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4211	usd
CY2022Q1	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	34001	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-348989	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1988921	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	98921	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-9461336	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3056189	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3062782	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1515515	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-5101	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	62315	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-128625	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	126986	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-14181	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	263712	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	483666	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-424198	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1112820	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4809928	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4411418	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	295018	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	368504	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	6807468	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-295018	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7175972	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	2623410	usd
CY2023Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	2915	usd
CY2023Q1	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	55849	usd
CY2022Q1	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	51708	usd
CY2022Q1	itp	Loan To A Related Partynet LoanToARelatedPartynet	6945022	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2564646	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6893314	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	146516	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28071	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7226072	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4156831	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9524868	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11201612	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16750940	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15358443	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	84040	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	85094	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	424198	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1112820	usd
CY2023Q1	itp	Cash And Bank Balances CashAndBankBalances	16750940	usd
CY2022Q1	itp	Cash And Bank Balances CashAndBankBalances	15358443	usd
CY2023Q1	itp	Total Cash Cash Equivalents And Restricted Cash TotalCashCashEquivalentsAndRestrictedCash	16750940	usd
CY2022Q1	itp	Total Cash Cash Equivalents And Restricted Cash TotalCashCashEquivalentsAndRestrictedCash	15358443	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	215749908	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	926138	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	886995	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	424546	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	18734461	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	27207127	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2488214	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	214187832	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	181323892	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	2502756	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2733165	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	181093483	usd
CY2022Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.001
CY2023Q1	us-gaap	Variable Interest Entity Ownership Percentage VariableInterestEntityOwnershipPercentage	1	pure
CY2010Q2	us-gaap	Capital Capital	60000000	usd
CY2023Q1	itp	Exercise Price Per Share ExercisePricePerShare	1
CY2010Q4	itp	Percentage Share Of Distributable Profit PercentageShareOfDistributableProfit	1	pure
CY2022Q1	itp	Percentage Of Revenue PercentageOfRevenue	0.9963	pure
CY2023Q1	us-gaap	Share Price SharePrice	0.001
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	290147294	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	286406838	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	140324411	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	134836940	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	149822883	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	151569898	usd
CY2023Q1	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary		usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	4942325	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1471436	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	150075	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	132810	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	877204	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1268376	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	5969604	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	2872622	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	5969604	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2872622	usd
CY2023Q1	itp	Prepaid Land Lease PrepaidLandLease	174629	usd
CY2022Q4	itp	Prepaid Land Lease PrepaidLandLease	172300	usd
CY2023Q1	itp	Prepayment For Purchase Of Materials PrepaymentForPurchaseOfMaterials	3557460	usd
CY2022Q4	itp	Prepayment For Purchase Of Materials PrepaymentForPurchaseOfMaterials	12941951	usd
CY2023Q1	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	14087543	usd
CY2022Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	13640868	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	27834	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	27462	usd
CY2023Q1	itp	Sale Leaseback Transaction Lease Period SaleLeasebackTransactionLeasePeriod	As of March 31, 2023 and December 31, 2022, land use rights represented twenty three parcels of state-owned lands located in Xushui District and Wei County of Hebei Province in China, with lease terms of 50 years expiring in 2061 and 2068, respectively.
CY2023Q1	itp	Pledged Asset Not Separately Reported Other Financial Instruments PledgedAssetNotSeparatelyReportedOtherFinancialInstruments	93136	usd
CY2023Q1	itp	Property Plant And Equipment Loan Drawn From Banking Facility PropertyPlantAndEquipmentLoanDrawnFromBankingFacility	4334537	usd
CY2022Q4	itp	Property Plant And Equipment Loan Drawn From Banking Facility PropertyPlantAndEquipmentLoanDrawnFromBankingFacility	4301204	usd
CY2023Q1	itp	Value Of Land Use Right Pledged For Sale Lease Back Financing ValueOfLandUseRightPledgedForSaleLeaseBackFinancing	3976123	usd
CY2022Q4	itp	Value Of Land Use Right Pledged For Sale Lease Back Financing ValueOfLandUseRightPledgedForSaleLeaseBackFinancing	3948953	usd
CY2023Q1	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	5396364	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	3686243	usd
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	3773236	usd
CY2020Q3	us-gaap	Net Investment In Lease Sale NetInvestmentInLeaseSale	16000000	usd
CY2023Q1	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.156	pure
CY2020Q3	itp	Inception Of Lease InceptionOfLease	567099	usd
CY2023Q1	itp	Lease Liability LeaseLiability	77789	usd
CY2022Q4	itp	Lease Liability LeaseLiability	131772	usd
CY2023Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	77789	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	131772	usd
CY2023Q1	itp	Amortization Of Lease Asset AmortizationOfLeaseAsset	38865	usd
CY2022Q1	itp	Amortization Of Lease Asset AmortizationOfLeaseAsset	42006	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	4490	usd
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	13507	usd
CY2023Q1	itp	Deferred Gain Amount DeferredGainAmount	430695	usd
CY2023Q1	itp	Minimum Leases Payments Sale Leaseback Transactions Next Rolling Twelve Months MinimumLeasesPaymentsSaleLeasebackTransactionsNextRollingTwelveMonths	80329	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2540	usd
CY2023Q1	itp	Lease Payment Gross LeasePaymentGross	77789	usd
CY2023Q1	itp	Less Current Portion Lease Liability LessCurrentPortionLeaseLiability	77789	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	36381	cny
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	36381	cny
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	608465	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y4M24D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0756	pure
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	5673996	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	5598311	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0472	pure
CY2022	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0479	pure
CY2023Q1	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	11778745	usd
CY2022Q4	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	9040002	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	11778745	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	9040002	usd
CY2023Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	5265073	usd
CY2022Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	4835884	usd
CY2023Q1	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	6513672	usd
CY2022Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	4204118	usd
CY2023Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	3327926	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	3294940	usd
CY2023Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	17325	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5265073	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	6487478	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	26194	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	11778745	usd
CY2003Q1	itp	Lease Term LeaseTerm	P2Y
CY2023Q1	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	2255628	usd
CY2015Q4	itp	Proceeds From Payments To Loan ProceedsFromPaymentsToLoan	2249279	usd
CY2014Q4	itp	Due Date DueDate	2017-12-10
CY2018Q1	itp	Proceeds From Payments To Loan ProceedsFromPaymentsToLoan	20400	usd
CY2023Q1	itp	Loan Due Description LoanDueDescription	Mr. Zhenyong Liu agreed to extend the loan for additional 3 years and the remaining balance was due on July 12, 2021.
CY2019Q4	itp	Proceeds From Payments To Loan ProceedsFromPaymentsToLoan	94636	usd
CY2023Q1	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	200006	usd
CY2022Q4	us-gaap	Other Borrowings OtherBorrowings	7276220	usd
CY2022Q4	us-gaap	Other Borrowings OtherBorrowings	7276220	usd
CY2022Q4	us-gaap	Other Borrowings OtherBorrowings	50000000	cny
CY2022Q4	us-gaap	Other Borrowings OtherBorrowings	50000000	cny
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	131553	usd
CY2023Q1	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	131800	usd
CY2022Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	3036	usd
CY2023Q1	us-gaap	Accrued Rent Current AccruedRentCurrent	93793	usd
CY2022Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	56646	usd
CY2023Q1	itp	Value Added Taxes Payable Current ValueAddedTaxesPayableCurrent	717	usd
CY2022Q4	itp	Value Added Taxes Payable Current ValueAddedTaxesPayableCurrent	69053	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	616691	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	19524	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	1781801	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1595354	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	23851	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18540	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	5993904	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	5665558	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	646283	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-152097	usd
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	494186	usd
CY2021Q1	itp	Aggregate Shares AggregateShares	2618182	shares
CY2021Q1	itp	Common Stock Issued To Purchase Of Warrants CommonStockIssuedToPurchaseOfWarrants	2618182	shares
CY2021Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	2618182	shares
CY2021Q1	itp	Gross Proceeds GrossProceeds	14400000
CY2023Q1	itp	Corresponding Price Per Share CorrespondingPricePerShare	5.5
CY2023Q1	itp	Exercise Price Per Warrant1 ExercisePricePerWarrant1	5.5
CY2021Q1	itp	Aggregate Shares Of Common Stock AggregateSharesOfCommonStock	2927786	shares
CY2021Q1	itp	Warrants To Purchase Shares WarrantsToPurchaseShares	1463893	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	1463893	shares
CY2021Q1	itp	Public Offering For Gross Proceeds PublicOfferingForGrossProceeds	21900000	usd
CY2023Q1	itp	Warrant Price Per Share WarrantPricePerShare	7.5
CY2023Q1	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	7.5
CY2022Q2	itp	Stock Issued During Period Price Per Share Reverse Stock Splits StockIssuedDuringPeriodPricePerShareReverseStockSplits	0.001
CY2022Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	150000	shares
CY2022Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	156000	usd
CY2020Q2	itp	Warrant Term Description WarrantTermDescription	These warrants become exercisable on July 23, 2020 and have a term of exercise equal to five years and six months from the date of issuance till July 23, 2025. 88,000 May 2020 Warrants were exercised in February 2021 at the exercise price of $7.425 per share and 352,000 May 2020 Warrants were outstanding as of March 31, 2023.
CY2021Q1	itp	Common Stock Issued To Purchase Stock CommonStockIssuedToPurchaseStock	2618182	shares
CY2021Q1	itp	Warrant Term Description WarrantTermDescription	The January 2021 Warrants became exercisable on January 20, 2021 at an exercise price of $5.5 and will expire on January 20, 2026. 1,410,690 January 2021 Warrants were exercised in January and February of 2021 at the exercise price of $5.5 per share. 1,207,492 January 2021 Warrants were outstanding as of March 31, 2023.
CY2021Q1	itp	Common Stock Issued To Purchase Stock CommonStockIssuedToPurchaseStock	1463893	shares
CY2021Q1	itp	Warrant Term Description WarrantTermDescription	The March 2021 Warrants became exercisable on March 1, 2021 at an exercise price of $7.5 and will expire on March 1, 2026. 6,750 March 2021 Warrants were exercised in January and March 2021 at the exercise price of $7.5 per share and 1,457,143 March 2021 Warrants were outstanding as of March 31, 2023.
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3016635	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.6907
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3016635	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.6907
CY2023Q1	itp	Schedule Of Outstanding And Exercisable Warrants ScheduleOfOutstandingAndExercisableWarrants	<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="5" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants Outstanding</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants Exercisable</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Weighted Average</td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Remaining</td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Contractual life</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Weighted Average</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Weighted Average</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(in years)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise Price</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 20%; text-align: center">3,016,635</td><td style="text-align: center; width: 1%"> </td> <td style="width: 19%; text-align: center">2.84</td><td style="text-align: center; width: 1%"> </td> <td style="width: 19%; text-align: center">$6.6907</td><td style="text-align: center; width: 1%"> </td> <td style="width: 19%; text-align: center">3,016,635</td><td style="text-align: center; width: 1%"> </td> <td style="width: 19%; text-align: center">$6.6907</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2733165	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2488214	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	10065920	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	9915920	shares
CY2023Q1	itp	Net Incomeloss Per Share NetIncomelossPerShare	-0.27
CY2022Q1	itp	Net Incomeloss Per Share NetIncomelossPerShare	-0.25
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2733165	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2488214	usd
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	10065920	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	9915920	shares
CY2023Q1	us-gaap	Weighted Average Basic Shares Outstanding Pro Forma WeightedAverageBasicSharesOutstandingProForma	10065920	shares
CY2022Q1	us-gaap	Weighted Average Basic Shares Outstanding Pro Forma WeightedAverageBasicSharesOutstandingProForma	9915920	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted Pro Forma Adjustment EarningsPerShareDilutedProFormaAdjustment	-0.27
CY2022Q1	us-gaap	Earnings Per Share Diluted Pro Forma Adjustment EarningsPerShareDilutedProFormaAdjustment	-0.25
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-348989	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-348989	usd
CY2022	itp	Description Of Carry Forwards Expire DescriptionOfCarryForwardsExpire	These carry forwards would expire, if not utilized, during the period of 2030 through 2035.
CY2023Q1	itp	Deferred Tax Assets Valuation Allowance Percentage DeferredTaxAssetsValuationAllowancePercentage	1	pure
CY2023Q1	itp	Deferred Tax Assets Depreciation Of Amortization Property Plant And Equipment Current DeferredTaxAssetsDepreciationOfAmortizationPropertyPlantAndEquipmentCurrent	15688773	usd
CY2022Q4	itp	Deferred Tax Assets Depreciation Of Amortization Property Plant And Equipment Current DeferredTaxAssetsDepreciationOfAmortizationPropertyPlantAndEquipmentCurrent	15474485	usd
CY2023Q1	itp	Deferred Tax Assets Impairment Of Amortization Property Plant And Equipment Current DeferredTaxAssetsImpairmentOfAmortizationPropertyPlantAndEquipmentCurrent	818158	usd
CY2022Q4	itp	Deferred Tax Assets Impairment Of Amortization Property Plant And Equipment Current DeferredTaxAssetsImpairmentOfAmortizationPropertyPlantAndEquipmentCurrent	796559	usd
CY2023Q1	itp	Deferred Tax Assets Miscellaneous Current DeferredTaxAssetsMiscellaneousCurrent	585399	usd
CY2022Q4	itp	Deferred Tax Assets Miscellaneous Current DeferredTaxAssetsMiscellaneousCurrent	615436	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	233286	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	213620	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17325616	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17100100	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17325616	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17100100	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	itp	Effect Of Different Tax Jurisdictionin Dollars EffectOfDifferentTaxJurisdictioninDollars	0.25	pure
CY2022Q1	itp	Effect Of Different Tax Jurisdictionin Dollars EffectOfDifferentTaxJurisdictioninDollars	0.25	pure
CY2023Q1	itp	Effect Of Expenses Not Deductible For Prc Tax Purposes EffectOfExpensesNotDeductibleForPrcTaxPurposes	-0.167	pure
CY2022Q1	itp	Effect Of Expenses Not Deductible For Prc Tax Purposes EffectOfExpensesNotDeductibleForPrcTaxPurposes	-0.127	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.083	pure
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.123	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0	pure
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.123	pure
CY2023Q1	itp	Income Tax Statute Of Limitations Period IncomeTaxStatuteOfLimitationsPeriod	P5Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	150000	shares
CY2022Q3	us-gaap	Employee Stock Ownership Plan Esop Number Of Suspense Shares EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares	150000	shares
CY2022Q3	us-gaap	Equity Fair Value Disclosure EquityFairValueDisclosure	156000	usd
CY2023Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	145745	usd
CY2023Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	1000000	cny
CY2013Q3	itp	Cash Prices Description CashPricesDescription	the Company’s Audit Committee and the Board of Directors approved the sale of the land use right of the Headquarters Compound (the “LUR”), the office building and essentially all industrial-use buildings in the Headquarters Compound (the “Industrial Buildings”), and three employee dormitory buildings located within the Headquarters Compound (the “Dormitories”) to Hebei Fangsheng for cash prices of approximately $2.77 million, $1.15 million, and $4.31 million respectively
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	145524	usd
CY2023Q1	itp	Commitments For Purchase Or Construction Of Capital Assets CommitmentsForPurchaseOrConstructionOfCapitalAssets	5930832	usd
CY2022Q4	itp	Commitments For Purchase Or Construction Of Capital Assets CommitmentsForPurchaseOrConstructionOfCapitalAssets	4329279	usd
CY2023Q1	itp	Performance Holdback On New Tissue Paper Payment Description PerformanceHoldbackOnNewTissuePaperPaymentDescription	The Company expected to pay off all the balances within 1-3 years.
CY2023Q1	itp	Longterm Loan From Financial Institutions LongtermLoanFromFinancialInstitutions	4511256	usd
CY2023Q1	itp	Longterm Loan From Financial Institutions LongtermLoanFromFinancialInstitutions	31000000	cny
CY2023Q1	itp	Concentration Credit Risk Percentage ConcentrationCreditRiskPercentage	0.14	pure
CY2015Q2	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	500000	cny
CY2015Q2	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	72762	usd
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	14684586	usd
CY2023Q1	us-gaap	Deferred Costs DeferredCosts		usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense		usd
CY2023Q1	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal		usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt		usd
CY2022Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt		usd
CY2023Q1	itp	Loan To A Related Partynet LoanToARelatedPartynet		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan		usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2023Q1	itp	Prepayment For Purchases Of Equipment PrepaymentForPurchasesOfEquipment		usd
CY2022Q4	itp	Prepayment For Purchases Of Equipment PrepaymentForPurchasesOfEquipment		usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability		usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost		cny
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments		cny
CY2023Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance		usd
CY2022Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance		usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther		usd
CY2022Q1	us-gaap	Interest Expense Other InterestExpenseOther		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2023Q1	itp	Addition Of New Derivatives Recognized As Warrant AdditionOfNewDerivativesRecognizedAsWarrant		usd
CY2023Q1	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative		usd
CY2023Q1	itp	Exercise Of Warrant ExerciseOfWarrant		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001358190

Files In Submission

Name	View Source	Status
itp-20230331_def.xml	Edgar Link	unprocessable
0001213900-23-038552-index-headers.html	Edgar Link	pending
0001213900-23-038552-index.html	Edgar Link	pending
0001213900-23-038552.txt	Edgar Link	pending
0001213900-23-038552-xbrl.zip	Edgar Link	pending
f10q0323ex31-1_ittechpack.htm	Edgar Link	pending
f10q0323ex31-2_ittechpack.htm	Edgar Link	pending
f10q0323ex32-1_ittechpack.htm	Edgar Link	pending
f10q0323ex32-2_ittechpack.htm	Edgar Link	pending
f10q0323_ittechpack.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
itp-20230331.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
itp-20230331_cal.xml	Edgar Link	unprocessable
f10q0323_ittechpack_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
itp-20230331_pre.xml	Edgar Link	unprocessable
itp-20230331_lab.xml	Edgar Link	unprocessable
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ITP
IT TECH PACKAGING, INC. Stock $itp

2023 Q2 Form 10-Q Financial Statement

#000121390023038552 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ITP IT TECH PACKAGING, INC. Stock $itp

2023 Q2 Form 10-Q Financial Statement

#000121390023038552 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ITP
IT TECH PACKAGING, INC. Stock $itp